Global Piroxicam Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 121

As the global economy mends, the 2021 growth of Piroxicam will have significant change from previous year. According to our (LP Information) latest study, the global Piroxicam market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Piroxicam market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Piroxicam market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Piroxicam market, reaching US$ million by the year 2028. As for the Europe Piroxicam landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Piroxicam players cover Pfizer, Teva, Mylan, and Nostrum, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- by Dosage Form

- - Suppositories

- - Injection

- - Capsule

- - Patch

- - Other

- by Route

- - Oral

- - Rectal

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Tendonitis

- Systemic Traumatic Pain

- Musculoskeletal Pain

- Contraception

- Rheumatoid Arthritis

- Chronic Infectious Arthritis

- Osteoarthritis

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Pfizer

- Teva

- Mylan

- Nostrum

- DCPC

- FANGMING

- JINGHUA

- JUMPCAN

- Technilab Pharma

- Apotex Corporation

- Keltman Pharmaceuticals

- Genpharm

- Bayer

- PLX Pharma

- Chiesi

- SK Chemicals

- Bioglan Laboratories

- APR

- CJ HealthCare

- SkyePharma

- Changzhou Siyao Pharmaceutical

- Shanxi Yunpeng Pharmaceutical

Global Piroxicam Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Piroxicam Market Size 2017-2028
2.1.2 Piroxicam Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Piroxicam Segment by Type
2.2.1 Suppositories
2.2.2 Injection
2.2.3 Capsule
2.2.4 Patch
2.2.5 Other
2.3 Piroxicam Market Size by Type
2.3.1 Piroxicam Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Piroxicam Market Size Market Share by Type (2017-2022)
2.4 Piroxicam Segment by Application
2.4.1 Tendonitis
2.4.2 Systemic Traumatic Pain
2.4.3 Musculoskeletal Pain
2.4.4 Contraception
2.4.5 Rheumatoid Arthritis
2.4.6 Chronic Infectious Arthritis
2.4.7 Osteoarthritis
2.4.8 Other
2.5 Piroxicam Market Size by Application
2.5.1 Piroxicam Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Piroxicam Market Size Market Share by Application (2017-2022)
3 Piroxicam Market Size by Player
3.1 Piroxicam Market Size Market Share by Players
3.1.1 Global Piroxicam Revenue by Players (2020-2022)
3.1.2 Global Piroxicam Revenue Market Share by Players (2020-2022)
3.2 Global Piroxicam Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Piroxicam by Regions
4.1 Piroxicam Market Size by Regions (2017-2022)
4.2 Americas Piroxicam Market Size Growth (2017-2022)
4.3 APAC Piroxicam Market Size Growth (2017-2022)
4.4 Europe Piroxicam Market Size Growth (2017-2022)
4.5 Middle East & Africa Piroxicam Market Size Growth (2017-2022)
5 Americas
5.1 Americas Piroxicam Market Size by Country (2017-2022)
5.2 Americas Piroxicam Market Size by Type (2017-2022)
5.3 Americas Piroxicam Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Market Size by Region (2017-2022)
6.2 APAC Piroxicam Market Size by Type (2017-2022)
6.3 APAC Piroxicam Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Piroxicam by Country (2017-2022)
7.2 Europe Piroxicam Market Size by Type (2017-2022)
7.3 Europe Piroxicam Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Piroxicam by Region (2017-2022)
8.2 Middle East & Africa Piroxicam Market Size by Type (2017-2022)
8.3 Middle East & Africa Piroxicam Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Piroxicam Market Forecast
10.1 Global Piroxicam Forecast by Regions (2023-2028)
10.1.1 Global Piroxicam Forecast by Regions (2023-2028)
10.1.2 Americas Piroxicam Forecast
10.1.3 APAC Piroxicam Forecast
10.1.4 Europe Piroxicam Forecast
10.1.5 Middle East & Africa Piroxicam Forecast
10.2 Americas Piroxicam Forecast by Country (2023-2028)
10.2.1 United States Piroxicam Market Forecast
10.2.2 Canada Piroxicam Market Forecast
10.2.3 Mexico Piroxicam Market Forecast
10.2.4 Brazil Piroxicam Market Forecast
10.3 APAC Piroxicam Forecast by Region (2023-2028)
10.3.1 China Piroxicam Market Forecast
10.3.2 Japan Piroxicam Market Forecast
10.3.3 Korea Piroxicam Market Forecast
10.3.4 Southeast Asia Piroxicam Market Forecast
10.3.5 India Piroxicam Market Forecast
10.3.6 Australia Piroxicam Market Forecast
10.4 Europe Piroxicam Forecast by Country (2023-2028)
10.4.1 Germany Piroxicam Market Forecast
10.4.2 France Piroxicam Market Forecast
10.4.3 UK Piroxicam Market Forecast
10.4.4 Italy Piroxicam Market Forecast
10.4.5 Russia Piroxicam Market Forecast
10.5 Middle East & Africa Piroxicam Forecast by Region (2023-2028)
10.5.1 Egypt Piroxicam Market Forecast
10.5.2 South Africa Piroxicam Market Forecast
10.5.3 Israel Piroxicam Market Forecast
10.5.4 Turkey Piroxicam Market Forecast
10.5.5 GCC Countries Piroxicam Market Forecast
10.6 Global Piroxicam Forecast by Type (2023-2028)
10.7 Global Piroxicam Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Piroxicam Product Offered
11.1.3 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Piroxicam Product Offered
11.2.3 Teva Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Piroxicam Product Offered
11.3.3 Mylan Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Nostrum
11.4.1 Nostrum Company Information
11.4.2 Nostrum Piroxicam Product Offered
11.4.3 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Nostrum Main Business Overview
11.4.5 Nostrum Latest Developments
11.5 DCPC
11.5.1 DCPC Company Information
11.5.2 DCPC Piroxicam Product Offered
11.5.3 DCPC Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 DCPC Main Business Overview
11.5.5 DCPC Latest Developments
11.6 FANGMING
11.6.1 FANGMING Company Information
11.6.2 FANGMING Piroxicam Product Offered
11.6.3 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 FANGMING Main Business Overview
11.6.5 FANGMING Latest Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Information
11.7.2 JINGHUA Piroxicam Product Offered
11.7.3 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 JINGHUA Main Business Overview
11.7.5 JINGHUA Latest Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Information
11.8.2 JUMPCAN Piroxicam Product Offered
11.8.3 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 JUMPCAN Main Business Overview
11.8.5 JUMPCAN Latest Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Information
11.9.2 Technilab Pharma Piroxicam Product Offered
11.9.3 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Technilab Pharma Main Business Overview
11.9.5 Technilab Pharma Latest Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Information
11.10.2 Apotex Corporation Piroxicam Product Offered
11.10.3 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Apotex Corporation Main Business Overview
11.10.5 Apotex Corporation Latest Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Information
11.11.2 Keltman Pharmaceuticals Piroxicam Product Offered
11.11.3 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Keltman Pharmaceuticals Main Business Overview
11.11.5 Keltman Pharmaceuticals Latest Developments
11.12 Genpharm
11.12.1 Genpharm Company Information
11.12.2 Genpharm Piroxicam Product Offered
11.12.3 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Genpharm Main Business Overview
11.12.5 Genpharm Latest Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Piroxicam Product Offered
11.13.3 Bayer Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Bayer Main Business Overview
11.13.5 Bayer Latest Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Information
11.14.2 PLX Pharma Piroxicam Product Offered
11.14.3 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 PLX Pharma Main Business Overview
11.14.5 PLX Pharma Latest Developments
11.15 Chiesi
11.15.1 Chiesi Company Information
11.15.2 Chiesi Piroxicam Product Offered
11.15.3 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Chiesi Main Business Overview
11.15.5 Chiesi Latest Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Information
11.16.2 SK Chemicals Piroxicam Product Offered
11.16.3 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 SK Chemicals Main Business Overview
11.16.5 SK Chemicals Latest Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Information
11.17.2 Bioglan Laboratories Piroxicam Product Offered
11.17.3 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Bioglan Laboratories Main Business Overview
11.17.5 Bioglan Laboratories Latest Developments
11.18 APR
11.18.1 APR Company Information
11.18.2 APR Piroxicam Product Offered
11.18.3 APR Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 APR Main Business Overview
11.18.5 APR Latest Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Information
11.19.2 CJ HealthCare Piroxicam Product Offered
11.19.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 CJ HealthCare Main Business Overview
11.19.5 CJ HealthCare Latest Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Information
11.20.2 SkyePharma Piroxicam Product Offered
11.20.3 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 SkyePharma Main Business Overview
11.20.5 SkyePharma Latest Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Information
11.21.2 Changzhou Siyao Pharmaceutical Piroxicam Product Offered
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Changzhou Siyao Pharmaceutical Main Business Overview
11.21.5 Changzhou Siyao Pharmaceutical Latest Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Information
11.22.2 Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Shanxi Yunpeng Pharmaceutical Main Business Overview
11.22.5 Shanxi Yunpeng Pharmaceutical Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Piroxicam Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Suppositories
Table 3. Major Players of Injection
Table 4. Major Players of Capsule
Table 5. Major Players of Patch
Table 6. Major Players of Other
Table 7. Piroxicam Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Piroxicam Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Piroxicam Market Size Market Share by Type (2017-2022)
Table 10. Piroxicam Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Piroxicam Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Piroxicam Market Size Market Share by Application (2017-2022)
Table 13. Global Piroxicam Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Piroxicam Revenue Market Share by Player (2020-2022)
Table 15. Piroxicam Key Players Head office and Products Offered
Table 16. Piroxicam Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Piroxicam Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Piroxicam Market Size Market Share by Regions (2017-2022)
Table 21. Americas Piroxicam Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Piroxicam Market Size Market Share by Country (2017-2022)
Table 23. Americas Piroxicam Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Piroxicam Market Size Market Share by Type (2017-2022)
Table 25. Americas Piroxicam Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Piroxicam Market Size Market Share by Application (2017-2022)
Table 27. APAC Piroxicam Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Piroxicam Market Size Market Share by Region (2017-2022)
Table 29. APAC Piroxicam Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Piroxicam Market Size Market Share by Type (2017-2022)
Table 31. APAC Piroxicam Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Piroxicam Market Size Market Share by Application (2017-2022)
Table 33. Europe Piroxicam Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Piroxicam Market Size Market Share by Country (2017-2022)
Table 35. Europe Piroxicam Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Piroxicam Market Size Market Share by Type (2017-2022)
Table 37. Europe Piroxicam Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Piroxicam Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Piroxicam Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Piroxicam Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Piroxicam Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Piroxicam Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Piroxicam Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Piroxicam Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Piroxicam
Table 46. Key Market Challenges & Risks of Piroxicam
Table 47. Key Industry Trends of Piroxicam
Table 48. Global Piroxicam Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Piroxicam Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Piroxicam Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Piroxicam Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Piroxicam Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Piroxicam Market Size Market Share Forecast by Application (2023-2028)
Table 54. Pfizer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 55. Pfizer Piroxicam Product Offered
Table 56. Pfizer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Teva Details, Company Type, Piroxicam Area Served and Its Competitors
Table 60. Teva Piroxicam Product Offered
Table 61. Teva Main Business
Table 62. Teva Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Teva Latest Developments
Table 64. Mylan Details, Company Type, Piroxicam Area Served and Its Competitors
Table 65. Mylan Piroxicam Product Offered
Table 66. Mylan Main Business
Table 67. Mylan Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Mylan Latest Developments
Table 69. Nostrum Details, Company Type, Piroxicam Area Served and Its Competitors
Table 70. Nostrum Piroxicam Product Offered
Table 71. Nostrum Main Business
Table 72. Nostrum Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Nostrum Latest Developments
Table 74. DCPC Details, Company Type, Piroxicam Area Served and Its Competitors
Table 75. DCPC Piroxicam Product Offered
Table 76. DCPC Main Business
Table 77. DCPC Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. DCPC Latest Developments
Table 79. FANGMING Details, Company Type, Piroxicam Area Served and Its Competitors
Table 80. FANGMING Piroxicam Product Offered
Table 81. FANGMING Main Business
Table 82. FANGMING Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. FANGMING Latest Developments
Table 84. JINGHUA Details, Company Type, Piroxicam Area Served and Its Competitors
Table 85. JINGHUA Piroxicam Product Offered
Table 86. JINGHUA Main Business
Table 87. JINGHUA Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. JINGHUA Latest Developments
Table 89. JUMPCAN Details, Company Type, Piroxicam Area Served and Its Competitors
Table 90. JUMPCAN Piroxicam Product Offered
Table 91. JUMPCAN Main Business
Table 92. JUMPCAN Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. JUMPCAN Latest Developments
Table 94. Technilab Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 95. Technilab Pharma Piroxicam Product Offered
Table 96. Technilab Pharma Main Business
Table 97. Technilab Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Technilab Pharma Latest Developments
Table 99. Apotex Corporation Details, Company Type, Piroxicam Area Served and Its Competitors
Table 100. Apotex Corporation Piroxicam Product Offered
Table 101. Apotex Corporation Main Business
Table 102. Apotex Corporation Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Apotex Corporation Latest Developments
Table 104. Keltman Pharmaceuticals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 105. Keltman Pharmaceuticals Piroxicam Product Offered
Table 106. Keltman Pharmaceuticals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Keltman Pharmaceuticals Main Business
Table 108. Keltman Pharmaceuticals Latest Developments
Table 109. Genpharm Details, Company Type, Piroxicam Area Served and Its Competitors
Table 110. Genpharm Piroxicam Product Offered
Table 111. Genpharm Main Business
Table 112. Genpharm Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Genpharm Latest Developments
Table 114. Bayer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 115. Bayer Piroxicam Product Offered
Table 116. Bayer Main Business
Table 117. Bayer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Bayer Latest Developments
Table 119. PLX Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 120. PLX Pharma Piroxicam Product Offered
Table 121. PLX Pharma Main Business
Table 122. PLX Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. PLX Pharma Latest Developments
Table 124. Chiesi Details, Company Type, Piroxicam Area Served and Its Competitors
Table 125. Chiesi Piroxicam Product Offered
Table 126. Chiesi Main Business
Table 127. Chiesi Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Chiesi Latest Developments
Table 129. SK Chemicals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 130. SK Chemicals Piroxicam Product Offered
Table 131. SK Chemicals Main Business
Table 132. SK Chemicals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. SK Chemicals Latest Developments
Table 134. Bioglan Laboratories Details, Company Type, Piroxicam Area Served and Its Competitors
Table 135. Bioglan Laboratories Piroxicam Product Offered
Table 136. Bioglan Laboratories Main Business
Table 137. Bioglan Laboratories Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Bioglan Laboratories Latest Developments
Table 139. APR Details, Company Type, Piroxicam Area Served and Its Competitors
Table 140. APR Piroxicam Product Offered
Table 141. APR Main Business
Table 142. APR Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. APR Latest Developments
Table 144. CJ HealthCare Details, Company Type, Piroxicam Area Served and Its Competitors
Table 145. CJ HealthCare Piroxicam Product Offered
Table 146. CJ HealthCare Main Business
Table 147. CJ HealthCare Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. CJ HealthCare Latest Developments
Table 149. SkyePharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 150. SkyePharma Piroxicam Product Offered
Table 151. SkyePharma Main Business
Table 152. SkyePharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. SkyePharma Latest Developments
Table 154. Changzhou Siyao Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 155. Changzhou Siyao Pharmaceutical Piroxicam Product Offered
Table 156. Changzhou Siyao Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 157. Changzhou Siyao Pharmaceutical Main Business
Table 158. Changzhou Siyao Pharmaceutical Latest Developments
Table 159. Shanxi Yunpeng Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 160. Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
Table 161. Shanxi Yunpeng Pharmaceutical Main Business
Table 162. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 163. Shanxi Yunpeng Pharmaceutical Latest Developments
List of Figures
Figure 1. Piroxicam Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piroxicam Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Piroxicam Market Size Market Share by Type in 2021
Figure 7. Piroxicam in Tendonitis
Figure 8. Global Piroxicam Market: Tendonitis (2017-2022) & ($ Millions)
Figure 9. Piroxicam in Systemic Traumatic Pain
Figure 10. Global Piroxicam Market: Systemic Traumatic Pain (2017-2022) & ($ Millions)
Figure 11. Piroxicam in Musculoskeletal Pain
Figure 12. Global Piroxicam Market: Musculoskeletal Pain (2017-2022) & ($ Millions)
Figure 13. Piroxicam in Contraception
Figure 14. Global Piroxicam Market: Contraception (2017-2022) & ($ Millions)
Figure 15. Piroxicam in Rheumatoid Arthritis
Figure 16. Global Piroxicam Market: Rheumatoid Arthritis (2017-2022) & ($ Millions)
Figure 17. Piroxicam in Chronic Infectious Arthritis
Figure 18. Global Piroxicam Market: Chronic Infectious Arthritis (2017-2022) & ($ Millions)
Figure 19. Piroxicam in Osteoarthritis
Figure 20. Global Piroxicam Market: Osteoarthritis (2017-2022) & ($ Millions)
Figure 21. Piroxicam in Other
Figure 22. Global Piroxicam Market: Other (2017-2022) & ($ Millions)
Figure 23. Global Piroxicam Market Size Market Share by Application in 2021
Figure 24. Global Piroxicam Revenue Market Share by Player in 2021
Figure 25. Global Piroxicam Market Size Market Share by Regions (2017-2022)
Figure 26. Americas Piroxicam Market Size 2017-2022 ($ Millions)
Figure 27. APAC Piroxicam Market Size 2017-2022 ($ Millions)
Figure 28. Europe Piroxicam Market Size 2017-2022 ($ Millions)
Figure 29. Middle East & Africa Piroxicam Market Size 2017-2022 ($ Millions)
Figure 30. Americas Piroxicam Value Market Share by Country in 2021
Figure 31. Americas Piroxicam Consumption Market Share by Type in 2021
Figure 32. Americas Piroxicam Market Size Market Share by Application in 2021
Figure 33. United States Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 34. Canada Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 35. Mexico Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 36. Brazil Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 37. APAC Piroxicam Market Size Market Share by Region in 2021
Figure 38. APAC Piroxicam Market Size Market Share by Application in 2021
Figure 39. China Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 40. Japan Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 41. Korea Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 42. Southeast Asia Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 43. India Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 44. Australia Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 45. Europe Piroxicam Market Size Market Share by Country in 2021
Figure 46. Europe Piroxicam Market Size Market Share by Type in 2021
Figure 47. Europe Piroxicam Market Size Market Share by Application in 2021
Figure 48. Germany Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 49. France Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 50. UK Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 51. Italy Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 52. Russia Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 53. Middle East & Africa Piroxicam Market Size Market Share by Region in 2021
Figure 54. Middle East & Africa Piroxicam Market Size Market Share by Type in 2021
Figure 55. Middle East & Africa Piroxicam Market Size Market Share by Application in 2021
Figure 56. Egypt Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 57. South Africa Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 58. Israel Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 59. Turkey Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Piroxicam Market Size Growth 2017-2022 ($ Millions)
Figure 61. Americas Piroxicam Market Size 2023-2028 ($ Millions)
Figure 62. APAC Piroxicam Market Size 2023-2028 ($ Millions)
Figure 63. Europe Piroxicam Market Size 2023-2028 ($ Millions)
Figure 64. Middle East & Africa Piroxicam Market Size 2023-2028 ($ Millions)
Figure 65. United States Piroxicam Market Size 2023-2028 ($ Millions)
Figure 66. Canada Piroxicam Market Size 2023-2028 ($ Millions)
Figure 67. Mexico Piroxicam Market Size 2023-2028 ($ Millions)
Figure 68. Brazil Piroxicam Market Size 2023-2028 ($ Millions)
Figure 69. China Piroxicam Market Size 2023-2028 ($ Millions)
Figure 70. Japan Piroxicam Market Size 2023-2028 ($ Millions)
Figure 71. Korea Piroxicam Market Size 2023-2028 ($ Millions)
Figure 72. Southeast Asia Piroxicam Market Size 2023-2028 ($ Millions)
Figure 73. India Piroxicam Market Size 2023-2028 ($ Millions)
Figure 74. Australia Piroxicam Market Size 2023-2028 ($ Millions)
Figure 75. Germany Piroxicam Market Size 2023-2028 ($ Millions)
Figure 76. France Piroxicam Market Size 2023-2028 ($ Millions)
Figure 77. UK Piroxicam Market Size 2023-2028 ($ Millions)
Figure 78. Italy Piroxicam Market Size 2023-2028 ($ Millions)
Figure 79. Russia Piroxicam Market Size 2023-2028 ($ Millions)
Figure 80. Spain Piroxicam Market Size 2023-2028 ($ Millions)
Figure 81. Egypt Piroxicam Market Size 2023-2028 ($ Millions)
Figure 82. South Africa Piroxicam Market Size 2023-2028 ($ Millions)
Figure 83. Israel Piroxicam Market Size 2023-2028 ($ Millions)
Figure 84. Turkey Piroxicam Market Size 2023-2028 ($ Millions)
Figure 85. GCC Countries Piroxicam Market Size 2023-2028 ($ Millions)
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs